Sharps Technology Secures Private Round Financing on August 25, 2025

According to media reports, Sharps Technology completed its Private round of financing on August 25, 2025. Notable investors in this round include Pantera Capital, ParaFi Capital, Borderless Capital, CoinFund, Arrington Capital, Primitive Ventures, Hypersphere Ventures, FalconX, RockawayX, and Quantstamp.Sharps Technology, listed on NASDAQ under the ticker STSS, is a medical device company specializing in the development and manufacturing of innovative safety syringes. The company’s core mission is to leverage its technology to reduce the risk of disease transmission caused by needlestick injuries, safeguarding healthcare professionals, patients, and the public, while enhancing the accuracy and efficiency of drug delivery. Recently, the company announced the establishment of a SOL treasury to further expand its business scope.Notably, following this round of financing, Sharps Technology rapidly increased its fundraising total to USD 1 billion and launched a digital asset treasury strategy. As of September 2, 2025, the company’s SOL holdings exceeded 2 million tokens, reflecting an active commitment to digital asset deployment. In addition, Sharps Technology completed over USD 400 million in PIPE private placement financing to create its SOL treasury. These initiatives underscore strong capital market confidence in the company’s future development.